tyrosine has been researched along with Venous Thrombosis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Djorgoski, I; Janevik-Ivanovska, E; Serafimovska, MD; Ugresic, M | 1 |
| Chen, SC; Cheng, PW; Chuang, YH; Li, PC; Ruan, JL | 1 |
| Corbi, P; Hajj-Chahine, J; Jayle, C; Tomasi, J | 1 |
| Sachithanandan, A | 1 |
| Berger, P; Blankenship, JC; Herrmann, H; Kalyanasundaram, A; McClure, R; Moliterno, D | 1 |
| Topaz, O | 1 |
| Henry, RG; Little, JW; McIntosh, BA; Miller, CS | 1 |
1 review(s) available for tyrosine and Venous Thrombosis
| Article | Year |
|---|---|
Antithrombotic agents: implications in dentistry.
Topics: Anticoagulants; Aspirin; Blood Coagulation Tests; Clopidogrel; Dental Care; Drug Interactions; Embolism; Fibrinolytic Agents; Hemostasis; Heparin; Heparin, Low-Molecular-Weight; Humans; Oral Hemorrhage; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Ticlopidine; Tirofiban; Tyrosine; Venous Thrombosis; Warfarin | 2002 |
1 trial(s) available for tyrosine and Venous Thrombosis
| Article | Year |
|---|---|
Thrombus predicts ischemic complications during percutaneous coronary intervention in saphenous vein grafts: results from TARGET (do Tirofiban and ReoPro give similar efficacy trial?).
Topics: Abciximab; Aged; Analysis of Variance; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Coronary Angiography; Coronary Disease; Double-Blind Method; Female; Graft Occlusion, Vascular; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Predictive Value of Tests; Reoperation; Research Design; Risk Factors; Saphenous Vein; Survival Analysis; Tirofiban; Treatment Outcome; Tyrosine; Venous Thrombosis | 2007 |
5 other study(ies) available for tyrosine and Venous Thrombosis
| Article | Year |
|---|---|
Imaging of deep venous thrombosis using radioactive-labeled tirofiban.
Topics: Animals; Disease Models, Animal; Male; Platelet Glycoprotein GPIIb-IIIa Complex; Radionuclide Imaging; Rats; Rats, Wistar; Technetium; Tirofiban; Tyrosine; Venous Thrombosis | 2015 |
In vitro evaluation of ultrasound-assisted thrombolysis using a targeted ultrasound contrast agent.
Topics: Animals; Biomarkers; Contrast Media; Dogs; Fibrinolytic Agents; Humans; Image Enhancement; Image Processing, Computer-Assisted; Microbubbles; Phantoms, Imaging; Reproducibility of Results; Serum Albumin; Sodium Chloride; Sonication; Thrombolytic Therapy; Tirofiban; Treatment Outcome; Tyrosine; Ultrasonics; Ultrasonography; Venous Thrombosis | 2009 |
Successful surgical management of massive pulmonary embolism during the second trimester in a parturient with heparin-induced thrombocytopenia.
Topics: Adult; Anticoagulants; Cardiopulmonary Bypass; Echocardiography, Transesophageal; Embolectomy; Enoxaparin; Female; Fondaparinux; Heart Arrest, Induced; Heparin; Humans; Infant, Newborn; Live Birth; Male; Polysaccharides; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Trimester, Second; Pulmonary Embolism; Thrombocytopenia; Tirofiban; Treatment Outcome; Tyrosine; Venous Thrombosis; Warfarin | 2010 |
Pulmonary embolectomy in heparin-induced thrombocytopenia and thrombosis? Safety of heparin use.
Topics: Anticoagulants; Cardiopulmonary Bypass; Embolectomy; Enoxaparin; Female; Fondaparinux; Heart Arrest, Induced; Heparin; Humans; Polysaccharides; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Trimester, Second; Pulmonary Embolism; Risk Assessment; Thrombocytopenia; Tirofiban; Treatment Outcome; Tyrosine; Ultrasonography; Venous Thrombosis; Warfarin | 2010 |
Ischemic coronary syndromes and SVG Interventions--do 2b/3a inhibitors miss the target?
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Combined Modality Therapy; Coronary Disease; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Syndrome; Tirofiban; Tyrosine; Venous Thrombosis | 2007 |